B-Raf IN 16

CAS No. 2304746-24-3

B-Raf IN 16( —— )

Catalog No. M37248 CAS No. 2304746-24-3

B-Raf IN 16, a BRAF inhibitor, belongs to cyclic iminopyrimidine derivatives and can be used for cancer or tumour research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    B-Raf IN 16
  • Note
    Research use only, not for human use.
  • Brief Description
    B-Raf IN 16, a BRAF inhibitor, belongs to cyclic iminopyrimidine derivatives and can be used for cancer or tumour research.
  • Description
    B-Raf IN 16 (Compound I) is a BRAF inhibitors that belongs a cyclic iminopyrimidine derivative. B-Raf IN 16 can be used for cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2304746-24-3
  • Formula Weight
    409.46
  • Molecular Formula
    C20H19N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC=1C(OC=2C=CC=3N=CN4C(=NCC4)C3C2)=CC=CC1NS(=O)(=O)CCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen Chen. Cyclic iminopyrimidine derivatives as kinase inhibitors
molnova catalog
related products
  • lavendustin C

    Lavendustin C is a potent inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase.

  • LXH254

    LXH254 (LXH-254, LXH 254) is a novel potent, ATP-competitive pan-RAF inhibitor, binds to Raf proteins and inhibits Raf-mediated signal transduction pathways.

  • PLX-7904

    A potent and selective BRaf inhibitor with IC50 of 5 nM against BRaf V600E in mutant RAS expressing cells.